Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in Type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S)-Reference-Cited by-同舟云学术

Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in Type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S)

Published:2014-05 Issue:3 Volume:28 Page:386-392
ISSN:1056-8727
Container-title:Journal of Diabetes and its Complications
language:en
Short-container-title:Journal of Diabetes and its Complications

Author:

Rosenstock Julio,Hanefeld Markolf,Shamanna Paramesh,Min Kyung Wan,Boka Gabor,Miossec Patrick,Zhou Tianyue,Muehlen-Bartmer Isabel,Ratner Robert E.

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference24 articles.

1. Efficacy and safety of lixisenatide once-daily morning or evening injections in type 2 diabetes inadequately controlled on metformin (GetGoal-M);Ahrén;Diabetes Care,2013

2. The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a review;Aroda;Diabetes/Metabolism Research and Reviews,2011

3. Efficacy and safety of lixisenatide once daily vs. placebo in people with Type 2 diabetes insufficiently controlled on metformin (GetGoal-F1);Bolli;Diabetic Medicine,2013

4. Exenatide-113 Clinical Study Group. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes;Buse;Diabetes Care,2004

5. The biology of incretin hormones;Drucker;Cell Metabolism,2006

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of continuous glucose monitoring when initiating glucagon‐like peptide‐1 receptor agonist therapy in insulin‐treated diabetes;Diabetes, Obesity and Metabolism;2024-08-28

2. The effect of subcutaneous Lixisenatide on weight loss in patients with type 2 Diabetes Mellitus: Systematic review and Meta-Analysis of randomized controlled trials;Diabetes Research and Clinical Practice;2024-04

3. Novel Antidiabetic Drugs and the Risk of Diabetic Retinopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Journal of Clinical Medicine;2024-03-20

4. Glucagon-like Peptide-1 Agonists;JBJS Reviews;2024-01

5. Effects of newer-generation anti-diabetics on diabetic retinopathy: a critical review;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-09-20